The Cure for What Ails Us Part I: What Makes This Virus Different From All Other Viruses? episode artwork

EPISODE · Apr 20, 2020 · 36 MIN

The Cure for What Ails Us Part I: What Makes This Virus Different From All Other Viruses?

from Wilmington Trust’s Capital Considerations · host Wilmington Trust

University of Pennsylvania microbiologist Susan Weiss, PhD, co-director of the Center for Research on Coronaviruses and Other Emerging Pathogens, joins Chief Investment Officer Tony Roth to discuss the origins of the coronavirus, a field Dr. Weiss has researched for more than four decades. Listen as Dr. Weiss walks us through the biology and epidemiology of COVID-19. 305912 -- Wilmington Trust Corporation is a wholly owned subsidiary of M&T Bank Corporation.

Episode metadata supplied by the publisher feed · Published Apr 20, 2020

Embed this episode

NOW PLAYING

The Cure for What Ails Us Part I: What Makes This Virus Different From All Other Viruses?

0:00 36:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Wilmington Trust’s Capital Considerations?

This episode is 36 minutes long.

When was this Wilmington Trust’s Capital Considerations episode published?

This episode was published on April 20, 2020.

Can I download this Wilmington Trust’s Capital Considerations episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!